Abstract
P471 Compliance, persistence and patient satisfaction in 150 mg once-monthly oral ibandronate treated patients with postmenopausal osteoporosis — A non-interventional study H. Borst*, D. Felsenberg, J. Glaab, O. Bock Centre for Muscle and Bone Research, Charite – University Medicine Berlin, Campus Benjamin Franklin, Berlin, Germany Business Unit Metabolism, Roche Pharma AG, Grenzach-Wyhlen, Germany
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
